Summary
The striatal dopamine metabolism of the rat was followed 1, 3, and 6 weeks after unilateral intranigral iron (III) (50- and 1.5 μg) application. For both concentrations a progredient decrease of extraneuronal 3.4-dihydroxyphenylacetic acid (DOPA) levels was observed in the ipsilateral striatum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arendash GW, Olanov CW, Sengstock GJ (1993) Intranigral iron infusion in rats: a progressive model for excess nigral iron levels in Parkinson's disease. In: Riederer P, Youdim MHB (eds) Iron in central nervous system disorders. Springer, Wien New York, pp 87–101 (key Topics in Brain Research)
Ben-Shachar D, Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical “Parkinsonism” in rats. J Neurochem 57: 2133–2135
Ben-Shachar D, Eshel G, Finberg JPM, Youdim MBH (1991a) The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal neurons. J Neurochem 56: 1441–1444
Ben-Shachar D, Riederer P, Youdim MBH (1991b) Iron melanin interaction and lipid peroxidation: implications for Parkinson's disease. J Neurochem 57: 1609–1614
Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989a) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381–389
Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989b) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830–1836
Dexter DT, Jenner P, Schapira AHV, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol [Suppl] 32: S94-S100
Floyd RA, Carney JM (1992) Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann Neurol [Suppl] 32: S22-S27
Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC (1985) Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett 62: 389–394
Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MBH (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J Neurochem 59: 1168–1171
Minotti G, Aust SD (1987) The requirement for iron (III) in the initiation of lipid peroxidation by iron (II), and hydrogen peroxide. J Biol Chem 262: 1098–1104
Nedergaard M, Goldman SA, Desai S, Pulsinelli WA (1991) Acid-induced death in neurons and glia. J Neurosci 11: 2489–2497
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52: 515–520
Sengstock GJ, Olanow CW, Menzies RA, Dunn AJ, Arendash GW (1993) Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers. J Neurosci Res 35: 67–82
Sloot WN, van der Sluijs-Gelling AJ, Gramsbergen JBP (1994) Selective lesions by managanese and extensive damage by iron after injection into rat striatum or hippocampus. J Neurochem 62: 205–216
Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains J Neurochem 56: 978–982
Ungerstedt U, Averno A, Averno E, Ljunbert T, Ranje C (1973) Animal model of Parkinsonism. In: Calne DB (ed) Advances in neurology, vol 3. Raven. New York, pp 257–271
Wesemann W, Grote C, Clement H-W, Block F, Sontag K-H (1993) Functional studies on monoaminergic transmitter release in Parkinson. Prog Neuropsychopharmacol Biol Psychiatry 17: 487–499
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wesemann, W., Blaschke, S., Solbach, M. et al. Intranigral injected iron progressively reduces striatal dopamine metabolism. J Neural Transm Gen Sect 8, 209–214 (1994). https://doi.org/10.1007/BF02260941
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02260941